Cambridge Cognition

By Heather Mack 03:41 pm February 27, 2017
Like many cognitive illnesses, clinical depression isn’t a steady state but a variable condition that has patterns and symptoms that change over time and throughout daily life. So Takeda Pharmaceuticals and Cognition Kit are collaborating on a study to assess whether mobile apps and wearables with continuous monitoring capabilities can be used to glean new insights into major depressive disorder...
By Jonah Comstock 03:09 pm January 23, 2017
UK-based cognitive assessment company Cambridge Cognition has received FDA clearance for Cantab Mobile, the company's iPad-based assessment tool for memory issues in older adults. The app, which already had a CE Mark, received FDA clearance January 13th. Cantab Mobile is a 10-minute test -- based on the Pairs Associates Learning or PAL test -- administered via a tablet that puts the user through...